Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia

por O'Brien, S G, Meinhardt, P, Bond, E, Beck, J, Peng, B, Dutreix, C, Mehring, G, Milosavljev, S, Huber, C, Capdeville, R, Fischer, T
Publicado 2003

Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours

por Campone, M, Levy, V, Bourbouloux, E, Berton Rigaud, D, Bootle, D, Dutreix, C, Zoellner, U, Shand, N, Calvo, F, Raymond, E
Publicado 2009